CTCZYME is the unique product containing β-mannanase, which degrades mannan to mannose or MOS for better utilization of nutrients and improved FCR in poultry and swine.
CTCZYME is a highly concentrated enzyme product of active β-mannanase produce by fermentation of a selected strain of Bacillus subtilis W-1.
CTC in CTCZYME Stands for following meaning: 
Creative: Creatively researched and developed by R&D CTCBIO with USA
Thermostable: Proven heat stability data in pellet (up to 900 C)
Cost saving: Energy creation by β-mannanase for 2.5~3 % downspec application 
Benefits of CTCZYME: 
- Degrades mannan to mannose or MOS
 - Improves glucose absorption rate and IGF-1 secretion
 - Makes MOS or mannose combine pathogenic bacteria
 - Improves FCR and ADG on poultry and swine
 - Reduces fecal and improves litter quality
 
Mannan is a polysaccharide which is mainly composed of mannose, it acts as an ANF (Anti-Nutrition Factor) in poultry, swine with negative impacts.
Mannan stays mainly at Palm kernel meal, Copra meal, SBM, and even at DDGS.  
Mannan's negative impacts:  
- Reduce the rate of Glucose absorption (Rainbird et al., 1984)
 - Interfere with insulin secretion and IGF-1 production (Nune and Malmhof, 1992)
 - Decrease nitrogen retention in intestine (F.H.Kratzer et al., 1964)
 - Increase viscosity in digestive system (Dale, 1997)
 
Specification:
- β-mannanase: Min. 800,000 u/kg
 - Solid form: Good stability and homogeneity
 - Dosage rate: 0.03~0.05
 
Patented in Korea, USA and Europe
   Korea            : 0390565, 0477456, 10-0560375
   USA               : 6,984,406
   Europe(EU) : EP 1292669 
93, Ctc Building, Ogeum dong, Songpa-gu, 
Seoul - Korea, 138-858
Telp. 82 2 3400 9874







Tidak ada komentar:
Posting Komentar